News-Medical.Net on MSN
Ligolab and Pathpresenter announce strategic partnership to deliver seamless digital pathology workflows
LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory ...
Pharmaceutical company Roche announced the expansion of its digital pathology open environment by integrating more than 20 advanced artificial intelligence algorithms from eight new collaborators. The ...
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA) to ...
Chicago, IL, April 21, 2025 (GLOBE NEWSWIRE) -- DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force in artificial intelligence-driven ...
Baylor College of Medicine has teamed with Leica Biosystems, a cancer diagnostics company and global leader in workflow solutions, to launch Baylor's worldwide pathology services. "Through creative ...
Medical Device Network on MSN
Lunit and CellCarta to integrate AI pathology in clinical trials
South Korean medical AI company Lunit and Canada-based research organisation CellCarta have partnered to integrate digital ...
PARIS--(BUSINESS WIRE)--Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the ...
Sacramento, Calif.-based UC Davis Health has received a $2.8 million grant from the National Institute of Biomedical Imaging and Bioengineering and National Institutes of Health to develop an AI-based ...
Pathology is the study of disease — its causes, effects and very nature. Studying disease is a very broad discipline that involves a wide range of scientists and medical professionals. Pathologists, ...
Pathologist shortage and recruitment, lab competitiveness and AI algorithms drive digital pathology adoption In the most traditional definition of return-on-investment, Sam Terese, former CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results